6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-09), Invivyd's 6-1 Month Momentum % is 12.05%.
The industry rank for Invivyd's 6-1 Month Momentum % or its related term are showing as below:
IVVD's 6-1 Month Momentum % is ranked better than 78.38% of 1466
companies
in the Biotechnology industry
Industry Median: -14.185
vs IVVD: 12.05
Competitive Comparison of Invivyd's 6-1 Month Momentum %
For the Biotechnology subindustry, Invivyd's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invivyd's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Invivyd's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Invivyd's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Invivyd 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Invivyd's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IVVD has been successfully added to your